StonvexLoading…
StonvexStonvexStonvexCore line items from LEVI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-08 | Q1 2026 2026-03-01 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-06-01 |
|---|---|---|---|---|---|
Revenue | $1.55B | $1.74B | $6.28B | $4.52B | $2.97B |
Operating Income | Not available | $198.70M | $677.60M | $467.00M | $299.60M |
Net Income | Not available | $175.80M | $578.10M | $420.10M | $202.00M |
EPS (Diluted) | $0.24 | $0.45 | $1.45 | $1.05 | $0.51 |
Total Assets | Not available | $6.57B | $6.85B | $6.66B | $6.53B |
Total Liabilities | Not available | $4.37B | $4.57B | $4.49B | $4.44B |
Cash & Equivalents | Not available | $716.60M | $757.90M | $612.80M | $653.60M |
Free Cash Flow OCF − CapEx | Not available | $152.10M | $308.20M | $92.50M | $131.90M |
Shares Outstanding | Not available | 394.20M | 399.75M | 400.40M | 400.11M |